invista

Introduction to invista

Invista is a medication available in tablet form primarily used to treat certain types of cancer, specifically leukemia. Invista is effective in managing conditions like chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), which affect the blood and bone marrow.

Composition of invista

Invista contains the active ingredient Dasatinib, which is a potent inhibitor of multiple tyrosine kinases. These proteins are involved in the growth and proliferation of cancer cells, and by inhibiting them, Dasatinib helps to slow down or stop the progression of cancer.

Uses of invista

• Treatment of chronic myeloid leukemia (CML)
• Treatment of acute lymphoblastic leukemia (ALL)

Side effects of invista

• Common side effects: Low blood cell counts, increased risk of infection, fluid retention, and swelling.
• Serious side effects: Severe liver problems, heart issues, and significant fluid retention requiring medical attention.

Precautions of invista

Before taking invista, inform your doctor if you have any allergies, especially to Dasatinib, or if you have severe liver problems. Regular monitoring is essential due to potential fluid retention and heart-related issues.

How to Take invista

Invista is typically taken as a tablet once daily, with or without food. It is important not to consume grapefruit or grapefruit juice while taking this medication. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of invista

Invista, containing the active ingredient Dasatinib, belongs to the therapeutic class of tyrosine kinase inhibitors. It is primarily used for treating chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Regular monitoring is crucial due to potential side effects. Invista is manufactured by a reputable pharmaceutical company, ensuring its quality and efficacy. For optimal results, adhere to your healthcare provider's guidance when using invista.